More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Capstan Therapeutics presents preclinical data on lead in vivo CAR-T candidate, CPTX2309, with plans to advance into the ...

Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

According to the American college of rheumatology, more than 790,000 knee replacements are performed annually in the U.S. and ...

Nektar Therapeutics (Nasdaq: NKTR) today announced its oral presentation highlighting preclinical data on NKTR-422 at the 2024 American College of Rheumatology (ACR) conference, being held in ...

There are multiple chapters near you. Select your preferred chapter.

Adds to growing body of evidence supporting the potential of ITK inhibition as a novel therapeutic for the treatment of a wide range of immune ...